HD-OPM Archive
Hashtags

#pancreaticcancer

13 posts

IV vitamin C plus chemotherapy doubled survival to 16 months in pancreatic cancer trial

Dec 04, 2024 · Louis Nervegna ♥ 22 · 💬 17 ↩ 1 Cancer

Louis shares a small randomized phase 2 trial at the University of Iowa in metastatic pancreatic cancer: high-dose intravenous vitamin C added to chemotherapy doubled median overall survival and was stopped early for benefit. He notes it is unrelated to heart disease and that IV vitamin C has a long controversial history.

Paricalcitol plus chemo safe in 36 pancreatic cancer patients; reduced tumor fibroblasts

Jun 05, 2026 · Louis Nervegna ♥ 8 · 💬 2 Cancer

Louis points to a Nature Cancer study from Dana-Farber in which the vitamin D analog paricalcitol was combined with chemotherapy in 36 patients with untreated metastatic pancreatic cancer. Biopsies showed reduced fibroblast activation and more T-cell infiltration; the trial was not designed to prove survival benefit and it is not about vitamin D supplements.

Daraxonrasib for pancreatic cancer already offered at Mass General Brigham

Aug 18, 2026 · Louis Nervegna ♥ 9 · 💬 1 Cancer

Louis reports that Mass General Brigham is treating pancreatic cancer patients with daraxonrasib through the FDA Expanded Access Program ahead of approval, and suggests other large hospitals may do the same. Coverage describes it as a historic pill that could double life expectancy in advanced disease.